General Biosystems is a leading biotech company based in the US, specializing in synthetic biology and gene synthesis. With a focus on microchip gene synthesis technology, they offer a comprehensive range of services to expedite and expand research involving genes and proteins. Their services include gene synthesis, mutagenesis, plasmid prep, biosystem optimization, cloning, protein expression, protein design, and customized services.

General Biosystems takes pride in offering these services at affordable prices while ensuring 100% sequence accuracy. The company is dedicated to understanding how genetic information is stored and programmed in DNA, using this knowledge to develop innovative technologies and instruments for programming and physically writing new genetic codes. Their goal is to generate new biofunctions and biosystems that will benefit human life and society in significant ways.

General Biosystems is staffed by scientists who are pioneers in genomics, proteomics, synthetic biology, and bioengineering. They have contributed to decoding the human genome and other genomics projects, as well as major cancer genome projects. Additionally, they have developed cutting-edge technologies for synthesizing oligonucleotide pools and gene libraries and optimizing protein expression.

In summary, General Biosystems is a forward-thinking biotech company driving advancements in synthetic biology and gene synthesis while offering a wide array of services to support researchers and companies in their genetic research endeavors